UNASSIGNED: While autologous and alloplastic options for breast reconstruction are well established, it is the advent of the combination of 3D printing technology and the biocompatible nature of a highly porous biodegradable implants that offers new treatment options for the future. While this type of prosthesis is not yet clinically available understanding how patients, surgeons, and nurses take up new medical innovations is of critical importance for efficient healthcare provision.
UNASSIGNED: Using the largest ever combined sample of breast cancer patients (n = 689), specialist surgeons (n = 53), and breast care nurses (n = 101), we explore participants preference for a new surgical treatment concept rooted in 3D printed and biodegradable implant technologies in the context of breast reconstruction.
UNASSIGNED: We find that patients overwhelmingly favor information from a successful patient of the proposed new technology when considering transitioning. Surgeons and nurses instead favor regulatory body advice, peer-reviewed journals, and witnessing the procedure performed (either in person or online). But while 1 in 4 nurses nominated talking to a successful patient as an information source, not a single surgeon chose the same. Our multinomial logit analysis exploring patient preference (controlling for individual differences) showed statistically significant results for both the type of surgical treatment and choice to undergo reconstruction. Women who underwent a type of mastectomy procedure (compared with lumpectomy patients) were more likely to choose a former patient than a surgeon for seeking information relating to a new breast implant technology. Further, women who chose to undergo a reconstruction procedure, compared with those who did not, where more likely to prefer a surgeon for information relating to a new breast implant technology, rather than a successful patient. For medical professionals, we find no statistically significant relationship between medical professionals\' preference and their age, nor the number of other medical professionals they work with daily, nor the average number of breast procedures performed in their practice on a weekly basis.
UNASSIGNED: As our findings show large variation exists (both within our patient group and compared with medical professionals) in where individuals favor information on new medical innovations, future behavioral research is warranted.
■虽然乳房重建的自体和异体选择已经确立,正是3D打印技术和高度多孔生物可降解植入物的生物相容性的结合的出现,为未来提供了新的治疗选择。虽然这种类型的假体还没有临床上了解患者如何,外科医生,和护士采取新的医疗创新是有效的医疗保健提供至关重要的。
■使用有史以来最大的乳腺癌患者合并样本(n=689),专业外科医生(n=53),和乳房护理护士(n=101),我们在乳房重建的背景下,探讨了参与者对植根于3D打印和可生物降解植入技术的新手术治疗概念的偏好.
■我们发现,在考虑过渡时,患者压倒性地偏爱来自所提出的新技术的成功患者的信息。外科医生和护士反而喜欢监管机构的建议,同行评审期刊,并见证所执行的程序(亲自或在线)。但是,当四分之一的护士被提名与成功的患者交谈作为信息来源时,没有一个外科医生选择了相同的。我们的多项logit分析探索患者偏好(控制个体差异)显示,手术治疗类型和接受重建的选择均具有统计学意义。接受某种乳房切除术的女性(与乳房肿瘤切除术患者相比)更有可能选择以前的患者,而不是外科医生来寻求与新的乳房植入技术有关的信息。Further,选择接受重建程序的妇女,与那些没有的人相比,更有可能选择外科医生获取与新乳房植入技术有关的信息,而不是一个成功的病人。对于医疗专业人员来说,我们发现医疗专业人员的偏好和他们的年龄之间没有统计学上显著的关系,也不是他们每天工作的其他医疗专业人员的数量,也不是他们每周进行的乳房手术的平均次数。
■由于我们的研究结果表明,在个人喜欢新的医疗创新信息的地方(在我们的患者群体内以及与医疗专业人员相比)存在很大的差异,未来的行为研究是有必要的。